William Blair & Company’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-102,021
Closed -$1.71M 1879
2022
Q1
$1.71M Sell
102,021
-84,500
-45% -$1.4M 0.01% 738
2021
Q4
$4.4M Buy
186,521
+52,466
+39% +$1.22M 0.01% 503
2021
Q3
$2.94M Buy
134,055
+17,801
+15% +$433K 0.01% 598
2021
Q2
$3.2M Buy
116,254
+3,486
+3% +$95.8K 0.01% 574
2021
Q1
$2.98M Buy
112,768
+10,452
+10% +$286K 0.01% 577
2020
Q4
$3.04M Buy
102,316
+786
+0.8% +$23.2K 0.01% 543
2020
Q3
$3.15M Sell
101,530
-2,148
-2% -$58.1K 0.01% 490
2020
Q2
$2.31M Buy
103,678
+39,315
+61% +$888K 0.01% 530
2020
Q1
$1.34M Buy
+64,363
New +$1.29M 0.01% 601

Other funds holding CLVT

William Blair & Company's CLVT Position: Q2 2022 in Review

William Blair & Company sold out of Clarivate (CLVT) in Q2 2022, closing a stake of 102,021 shares — an estimated $1.71M sold.

William Blair & Company first reported a position in CLVT in Q1 2020 and held it in 9 quarters. The position peaked at $4.4M in Q4 2021. 283 funds tracked by Wall St. Rank hold CLVT as of Q2 2022.

  • William Blair & Company reported no remaining Clarivate position as of Q2 2022 after selling out during the quarter.
  • William Blair & Company sold 102,021 Clarivate shares in Q2 2022, an estimated $1.71M.
  • William Blair & Company first reported a position in Clarivate in Q1 2020 and held it in 9 quarters.
  • William Blair & Company's Clarivate position peaked at $4.4M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held Clarivate as of Q2 2022.

Based on William Blair & Company's 13F filing for Q2 2022, filed 10 Aug 2022.